A Study With Teduglutide (Revestive®) in Adults With Short Bowl Syndrome
Clinical trial NCT04883606 · COMPLETED
Trial details
- NCT number
- NCT04883606
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-26
- Primary completion
- 2023-07-24
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.